Hodges Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,524
| Closed | -$585K | – | 224 |
|
|
2020
Q4 | $585K | Sell |
6,524
-9,323
| -59% | -$836K | 0.09% | 147 |
|
|
2020
Q3 | $1.64M | Sell |
15,847
-50,815
| -76% | -$5.25M | 0.32% | 95 |
|
|
2020
Q2 | $5.27M | Buy |
66,662
+30,089
| +82% | +$2.38M | 1.08% | 26 |
|
|
2020
Q1 | $2.12M | Buy |
+36,573
| New | +$2.12M | 0.54% | 60 |
|
|
2018
Q2 | – | Sell |
-30,000
| Closed | -$1.58M | – | 254 |
|
|
2018
Q1 | $1.58M | Sell |
30,000
-25,000
| -45% | -$1.32M | 0.12% | 131 |
|
|
2017
Q4 | $2.56M | Sell |
55,000
-25,000
| -31% | -$1.16M | 0.19% | 105 |
|
|
2017
Q3 | $3.24M | Hold |
80,000
| – | – | 0.22% | 98 |
|
|
2017
Q2 | $2.71M | Buy |
80,000
+25,000
| +45% | +$848K | 0.16% | 112 |
|
|
2017
Q1 | $1.6M | Buy |
55,000
+22,000
| +67% | +$639K | 0.08% | 142 |
|
|
2016
Q4 | $1.08M | Buy |
+33,000
| New | +$1.08M | 0.05% | 166 |
|